#medical device clinical trials training | Explore Tumblr Posts and Blogs

afeelgoodblog · 1 year

Text

The Best News of Last Year

1. Belgium approves four-day week and gives employees the right to ignore their bosses after work

Workers in Belgium will soon be able to choose a four-day week under a series of labour market reforms announced on Tuesday.

The reform package agreed by the country's multi-party coalition government will also give workers the right to turn off work devices and ignore work-related messages after hours without fear of reprisal.

"We have experienced two difficult years. With this agreement, we set a beacon for an economy that is more innovative, sustainable and digital. The aim is to be able to make people and businesses stronger," Belgian prime minister Alexander de Croo told a press conference announcing the reform package.

2. Spain makes it a crime for pro-lifers to harass people outside abortion clinics

Spain has criminalized the harassment or intimidation of women going for an abortion under new legislation approved on Wednesday by the Senate. The move, which involved changes to the penal code, means anti-abortion activists who try to convince women not to terminate their pregnancies could face up to a year behind bars.

3. House passes bill to federally decriminalize marijuana

The House has voted with a slim bipartisan majority to federally decriminalize marijuana. The vote was 220 to 204.

The bill, sponsored by Democratic Rep. Jerry Nadler of New York, will prevent federal agencies from denying federal workers security clearances for cannabis use, and will allow the Veterans’ Administration to recommend medical marijuana to veterans living with posttraumatic stress disorder.

The bill also expunges the record of people convicted of non-violent cannabis offenses, which House Majority Leader Steny Hoyer said, “can haunt people of color and impact the trajectory of their lives and career indefinitely.”

4. France makes birth control free for all women under 25

The scheme, which could benefit three million women, covers the pill, IUDs, contraceptive patches and other methods composed of steroid hormones.

Contraception for minors was already free in France. Several European countries, including Belgium, Germany, the Netherlands and Norway, make contraception free for teens.

5. The 1st fully hydrogen-powered passenger train service is now running in Germany. The only emissions are steam & condensed water.

Five of the trains started running in August. Another nine will be added in the coming months to replace 15 diesel trains on the regional route. Alstom says the Coradia iLint has a range of 1,000 kilometers, meaning that it can run all day on the line using a single tank of hydrogen. A hydrogen filling station has been set up on the route between Cuxhaven, Bremerhaven, Bremervörde and Buxtehude.

6. Princeton will cover all tuition costs for most families making under $100,000 a year, after getting rid of student loans

In September, the New Jersey Ivy League school announced it would be expanding its financial aid program to offer free tuition, including room and board, for most families whose annual income is under $100,000 a year. Previously, the same benefit was offered to families making under $65,000 a year. This new income limit will take effect for all undergraduates starting in the fall of 2023.

Princeton was also the first school in the US to eliminate student loans from its financial aid packages.

7. Humpback whales no longer listed as endangered after major recovery

Humpback whales will be removed from Australia's threatened-species list, after the government's independent scientific panel on threatened species deemed the mammals had made a major recovery. Humpback whales will no longer be considered an endangered or vulnerable species.

Climate change and fishing still pose threats to their long-term health.

Some other uplifting news from last year:

A Cancer Trial’s Unexpected Result: Remission in Every Patient

California 100 percent powered by renewables for first time

Israel formally bans LGBTQ conversion therapy

Tokyo Passes Law to Recognize Same-Sex Partnerships

First 100,000 KG Removed From the Great Pacific Garbage Patch

As we ring in the New Year let’s remember to focus on the good news. May this be a year of even more kindness and generosity. Wishing everyone a happy and healthy 2023!

Thank you for following and supporting this g this newsletter

Buy me a coffee ❤️

#best news of last week

1K notes · View notes

where-dreams-dwell · 6 months

Text

It’s almost like the Usher children *knew* they weren’t going to live long and so they intentially left no marks upon the world.

Camille’s speech about how none of the kids actually makes or does anything is so startling: here is a group of people given all the opportunities and access money can buy, all of whom have had this their entire adult life, and they haven’t used it to create or build anything.

You can almost sense Roderiks disappointment in them, in his speech to Perry. He has this hyper focus on what his ‘investment’ money will fund, and says that ‘Ushers change the world’. But outside of himself and Madeline, not one of them has.

Frederick took the money, if he ever got any, and probably funnelled it back into his house or the company. By the looks of it he doesn’t have anything other than his family and his job, so there’s nothing for Roderick to invest in.

Tammy funnelled the money into a lifestyle brand, but one that wouldn’t have her at the front and centre. She scathingly reveals to Bill that she selected him to be her husband based upon his brand and marketability, showing she was ready to create this new empire but with her pulling strings in the shadows. From the outside it probably looks like she hasn’t created anything at all and that it’s all Bill, using his wife’s money. On top of this, the running gag of her storyline is that her brand and ideas aren’t even original, but are ripped off of Goop. So she hasn’t made anything new, and if Goldbug has any impact at all it will be no different to another more successful, more well know product. Hardly ‘changing the world’.

Victorine has some medial training but she looks to be a supporting role to her partner within their clinic, in which Al is the talented surgeon who people come to see and Victorine is a kind of silent partner. So she decided to go into medical devices or smart medical tech, but she relies upon the ideas and skills of others. As Camille said ‘the mesh is the surgeons, that’s why she’s fucking the surgeon’. And her medical knowledge seems to be limited if she thinks just her word and some money will move their experiments into human trials. So she also hasn’t ‘changed the world’ she’s just found someone else who was trying to and co-op-ed their ideas. You could even argue she poisoned those ideas, as Al mentions that the pain medication Victorine has been supplying looks like street drugs and wouldn’t stand up in any medical paper or research study.

Camille is, like she said, spinning furiously and going nowhere. She looks skilled in her field (from the analysis scenes we get, and Madeleine’s signing off on her PR analysis post Perry’s death) but she works from the shadows and hasn’t ‘created’ anything that wasn’t there before. There have been PR spin doctors before and there will be more to come; Camille offers nothing new ans hasn’t ‘changed the world’ in any measurable way. From what little we see of her work she hasn’t recreated a PR agency, hasn’t trained up other spin doctors under her, hasn’t created a brand or company which will outlast her. She leaves nothing behind to show what her skills or talents were.

Leo is shot down quickly when he claims he makes games: he doesn’t, he gives money to people who do. So he too will leave little to nothing behind when he’s gone. His references to past boyfriends show no long lasting relationships in his life and he has no other hobbies or pursuits we know of. Like Camille he hasn’t created a company to help with game design, hasn’t trained up others within this field he claims as his own. Even with the gaming ‘world’ it sounds like he changed very little. Fredrick’s throw away comments about Leo’s flat reveal that Leo hadn’t even had input in the decoration or style of his own home: he just latches onto the styles, ideas, aesthetic of his current boyfriend and goes with their ideas and plans. It’s such a small tiny thing but he truly has no original ideas in any aspect of his life.

And finally Perry, who’s desperate for that start up money but clearly has no plans or ideas on how to use it. He’s had a year and his main idea is an exclusive whisky bar. Even this idea, for all its crude intentions, shows his lack of vision: he doesn’t understand that to get the reputation he claims his bars would have will take time. You don’t just ‘create’ a consequent free bar celebrating decadence and privilege overnight. Reputations take time and as Madeline asks ‘what will be different about this one’ to draw people in to begin with? Studio 54 (which he compares his club to). only operated for 3 years before closing: not the smartest inclusion in an investment pitch.

To be fair to Perry though, looking at what the other siblings did or didn’t do with their loan money it seems a bit unfair that his ‘Blow job whiskey bar’ was shot down so decisively and cruelty. Assuredly Leo’s ‘video game studio for just myself’, Camille’s ‘PR agency just for me with my two assistants’, Victorines ‘medical training and clinic where I help out other surgeons’, Tammys ‘subscription lifestyle brand ripped off from a celebrity’ and Fredrick’s ‘I’d just like to work with you Dad’ were all clearly given the green light. But Perry apparently wasn’t good enough. Maybe this was a reaction to Roderick getting the news he was dying as so he wanted Perrys investment at least to actually change something, but still. He might as well give him the money either way at that point.

And I think it’s probably intended as a commentary on the ultra wealthy. Like of course people with more money than most counties have no plans to leave anything for the next generation. They have achieved their high levels of success by being solely focused upon themselves and so are honestly incapable of considering others. They are solely interested in enjoying the life they are currently living and why strain themselves to fight and build something when they don’t have to?

But it also works so well as a supernatural legacy and ironic conclusion to Roderick’s deal: he agreed that none of his bloodline would outlive him, and so none of them built anything that would.

#the fall of the house of usher #spoilers #mike flanagan #tfothou #legacy #ultra wealthy

116 notes · View notes

aboardtheichthyoid · 8 months

Note

Heyyy Steve... could you tell me about Larissa Elliot? From the fragments I've seen on this blog, she(?) seems awesome.

Yes! Thank you so much for asking! Larissa is amazing and I love her dearly. A lot about her is kind of hidden in the beginning of the story, until the search team uncovers more about what happened. This got away from me, so I'll put it under the read more.

Larissa is in her mid 30s. She was the doctor on the original crew of the Ichthyoid. She always wanted to work in medical research, but she couldn't get into that program (many of those jobs went to children of citizens). However, she was accepted into the MD program and hoped that after her contract was completed she could transition to clinical trials at least. Her mentor was working on an implant to help stimulate tissue growth, and she really hoped to be a part of that project. She thought that his ideas could push humanity far beyond their current capability.

She met her mentor not during her medical training, as you might expect, but when she was a teenager. Her parents died when she was young in an accident, and she became a ward of the corporation they were citizens of, Apollon. She was in the central library of Apollon studying when her mentor went to the desk to ask for assistance in finding a biomedical textbook. When he noticed that she was eavesdropping, he struck up a conversation and quickly took her under his wing.

She was never much of a 'people person' and didn't interact with the other crew members more than she had to. She chose to offset her sleep/wake cycle so that she had a smaller chance of running into them. However, she would talk to the chemist, Ada, to discuss the experiments they planned to run when they reached their destination. After a few late nights talking, Ada confessed her feelings for Larissa and they started to date. This was against company policy, but fairly common on long haul missions, so they barely tried to conceal it.

Outside of work, she was a voracious reader, having read just about every book published on biomedical engineering in the past 10 years. She kept in touch with her mentor. She didn't have many other people to talk to, because her former classmates were often on long haul or confidential missions, where communications were heavily restricted. She missed her best friend and left messages on her personal device frequently, hoping that she would return and contact Larissa before she left on the Ichthyoid. She never did hear back from her.

Now, the things you've seen me tag her in might make you think I'm leaving something out, and I am! But it's super integral to the story so I can't give too much away :P

#larissa elliot #characters #answered #as you can tell I haven't decided on her mentor's name yet #oops

5 notes · View notes

croservices · 1 year

Text

What is CRO and its role in clinical trials?

CRO stands for Clinical Research Organization. It is an organization that provides services to the pharmaceutical, biotechnology, and medical device industries to assist in the clinical development of their products. CRO`s provide a range of services, including clinical trial design, protocol development, data management, statistical analysis, and regulatory affairs.

They also provide support for clinical trial sites, such as patient recruitment, training, and monitoring. CROs play an important role in the clinical trial process, as they help to ensure that the trial is conducted in a safe and ethical manner, and that the data collected is accurate and reliable.

What is the basic principle of Clinical Research Organization?

The basic principle of Clinical Research Organization (CRO) is to provide services to the pharmaceutical, biotechnology, and medical device industries to help them develop new drugs, treatments, and medical devices.

Clinical Research Organization provide a range of services, including clinical trial design, data management, regulatory affairs, and quality assurance. They also provide expertise in areas such as clinical trial management, data analysis, and statistical analysis.

What are the main components of Clinical Research Organization?

1. Regulatory Affairs: This includes the development and implementation of regulatory strategies, preparation of regulatory documents, and communication with regulatory authorities.

2. Clinical Operations: This includes the management of clinical trials, including protocol design, site selection, patient recruitment, data collection, and data management.

3. Quality Assurance: This includes the development and implementation of quality systems, monitoring of clinical trials, and auditing of clinical sites.

4. Data Management: This includes the collection, storage, and analysis of clinical trial data.

5. Medical Writing: This includes the preparation of clinical trial documents, such as protocols, investigator brochures, and clinical study reports.

6. Project Management: This includes the coordination of all aspects of a clinical trial, including budgeting, timelines, and resource allocation.

#CRO #CRO`s #Health #Healthcare #News #Article #Tumblr

3 notes · View notes

localhakim · 2 days

Text

Biotech Breakthroughs - Ethical Concerns About Gene Editing

One of the most exciting developments in biotechnology has been the ability to manipulate DNA in living organisms with unprecedented precision. This has allowed researchers to insert new genes into cells, modify existing ones, or delete disease-related ones. It’s a game-changer that has the potential to revolutionize medicine, but it also raises ethical questions about how people may use this technology in the future.

A major concern is that the technology could be used for eugenic purposes, such as eliminating certain genetic traits in future generations. These concerns are heightened by the fact that embryos can be genetically edited, which would allow scientists to change the genome of future tech ogle children. The first case of editing the genes of human embryos was reported in 2019 by Chinese scientists who inserted a gene that prevents HIV infection into twin fetuses. This raises concerns about what is being called “genetic engineering” or “designer babies.”

The vast majority of U.S. adults say they are very or somewhat worried about the possibility of gene editing being used to greatly reduce a baby’s risk of serious diseases and health conditions over their lifetime. But they’re less skeptical that the technology will lead to medical advances that benefit society overall. Roughly six-in-ten Americans say gene editing will definitely or probably make it possible for people to live much healthier lives. And two-thirds think that if genetically editing is technology news widely used, it will be done in ways that are morally acceptable.

Other important innovations in the field of biotechnology include 3-D printing and biosensors. 3-D printing enables scientists to create living tissues and organs for medical research and training. Biosensors are small devices that can detect chemicals or biological signals and then respond in a specific way. This type of technology has the potential to improve clinical trials, drug development, and diagnostic testing.

There is also a growing interest in synthetic biology, which involves building living organisms from the components of existing life forms. Scientists can build complex genetically modified microbes to perform a wide range of tasks, from improving the efficiency of a fermentation process to synthesizing proteins that have never been produced before.

Some researchers believe that the development of gene editing will lead to a time when humans can choose which traits they want to pass on to their offspring, such as intelligence or athletic ability. This has the potential to reshape society and culture. But many experts warn that it will be difficult to maintain a balance between the beneficial and harmful effects of the technology, especially if the power to edit genes is in the hands of a few wealthy individuals. In addition, the risks of errors in editing genes or introducing undesired side effects are real. A recent study found that the accuracy of CRISPR gene editing is only about 10%. As a result, it will likely take years for this technology to be used in clinical applications. Even so, many scientists are optimistic that it will eventually become a mainstream tool for preventing and treating diseases.

1 note · View note

obesity-reduction · 2 days

Text

The Evolution of Weight Loss Surgery: From Traditional Methods to Intragastric Balloon

In the realm of medical advancements, the evolution of weight loss surgery stands as a testament to the relentless pursuit of healthier lives for those grappling with obesity. As a seasoned medical professional deeply invested in bariatric surgery and metabolic diseases, it’s fascinating to witness the journey from conventional approaches to innovative techniques like the Intragastric Balloon (IGB).

Allow me to introduce myself: Dr. Shashank Shah, a distinguished figure in the field of weight loss surgery and laparoscopic surgery. With a repertoire of qualifications including an M.B.B.S., M.S., FAIS, and honorary affiliations with esteemed medical societies, my journey has been dedicated to transforming lives through comprehensive obesity treatment and surgical interventions.

At the helm of the Laparo-Obeso Centre, a beacon of excellence in bariatric and metabolic surgery, I’ve had the privilege of witnessing the evolution of weight loss surgery firsthand. Our center, affiliated with Boston University for bariatric training programs, serves as a training ground for aspiring surgeons, fostering innovation and expertise in the realm of obesity management.

Traditionally, weight loss surgery predominantly comprised procedures like gastric bypass and sleeve gastrectomy, which aimed to reduce stomach capacity and alter digestive processes. While these techniques have proven efficacy, the landscape of weight loss surgery has expanded with the introduction of minimally invasive approaches and innovative devices.

One such innovation that has garnered attention is the Intragastric Balloon (IGB). This non-surgical procedure involves placing a deflated balloon into the stomach, which is then inflated to occupy space and induce a feeling of fullness. Unlike traditional surgeries, the IGB offers a less invasive option for individuals seeking weight loss interventions.

The journey towards the adoption of IGB in weight loss surgery has been marked by rigorous research, clinical trials, and advancements in medical technology. As a proponent of evidence-based practice, I’ve closely followed the evolution of IGB and its integration into comprehensive obesity treatment protocols.

The appeal of IGB lies in its minimally invasive nature, shorter recovery times, and potential for reversible weight loss interventions. For individuals who may not be suitable candidates for traditional bariatric surgeries due to various reasons, such as medical comorbidities or surgical risks, IGB offers a viable alternative.

Moreover, the versatility of IGB extends beyond weight loss alone. Studies have demonstrated its efficacy in improving metabolic parameters, such as glycemic control in individuals with type 2 diabetes, further highlighting its potential as a tool for holistic metabolic health management.

As we navigate the ever-evolving landscape of weight loss surgery, it’s imperative to prioritize patient-centric care, tailored interventions, and multidisciplinary approaches. At the Laparo-Obeso Centre, we remain committed to advancing the field of bariatric and metabolic surgery, leveraging innovative techniques like the Intragastric Balloon to empower individuals on their journey towards healthier lives.

In conclusion, the evolution of weight loss surgery from traditional methods to innovative approaches like the Intragastric Balloon underscores the transformative power of medical advancements in combating obesity and metabolic diseases. With a focus on evidence-based practice and patient-centered care, the future of bariatric surgery holds promise for continued innovation and improved outcomes.

#Intragastric Balloon #Bariatric Surgery #Laparo Obeso Center #Weight Loss Surgery #Dr Shashank Shah

0 notes

doctormoustafamoustafa · 3 days

Text

Nephrology Nexus: Collaborative Efforts to Tackle Kidney Health Challenges

Introduction

In the intricate web of healthcare, nephrology emerges as a nexus where collaborative efforts among healthcare professionals, researchers, policymakers, and patients converge to tackle the multifaceted challenges of kidney health. This article explores the collaborative initiatives in nephrology aimed at addressing the diverse array of kidney health challenges and improving outcomes for individuals worldwide.

Interdisciplinary Collaboration

At the heart of nephrology nexus lies the ethos of interdisciplinary collaboration, where clinicians, researchers, and allied healthcare professionals work synergistically to address the complex needs of patients with kidney diseases. Multidisciplinary care teams, comprising nephrologists, nurses, dietitians, social workers, pharmacists, and transplant coordinators, collaborate to provide comprehensive, patient-centered care tailored to individual needs.

Interdisciplinary collaboration extends beyond clinical care to encompass research consortia, quality improvement initiatives, and advocacy efforts aimed at advancing the field of nephrology and improving kidney health outcomes. By fostering collaborative partnerships among stakeholders, the nephrology nexus harnesses collective expertise, resources, and insights to tackle kidney health challenges from multiple angles.

Research Consortia and Translational Partnerships

Research consortia and translational partnerships serve as catalysts for innovation and discovery in nephrology, bringing together investigators from diverse disciplines to tackle pressing research questions and translate scientific findings into clinical practice. Collaborative research endeavors, such as cohort studies, biobanks, and clinical trials, enable investigators to leverage pooled resources, data, and expertise to advance knowledge and inform evidence-based practice.

Translational partnerships between academia, industry, and healthcare organizations facilitate the translation of research discoveries into tangible clinical applications, such as diagnostic tools, therapeutic interventions, and medical devices. By fostering collaboration between bench and bedside, translational partnerships accelerate the pace of innovation, improve patient outcomes, and shape the future of renal care.

Patient Engagement and Advocacy

At the core of the nephrology nexus lies the voice of the patient, whose experiences, perspectives, and preferences inform and guide collaborative efforts to improve kidney health outcomes. Patient engagement initiatives, such as patient advisory councils, peer support groups, and patient-reported outcome measures (PROMs), empower individuals with kidney diseases to actively participate in their care, share their lived experiences, and advocate for their needs.

Moreover, patient advocacy organizations play a crucial role in raising awareness about kidney health, advocating for policies that promote access to care and research funding, and providing support and resources to individuals affected by kidney diseases. By amplifying the voices of patients and caregivers, the nephrology nexus ensures that collaborative efforts are patient-centered, responsive to patient needs, and inclusive of diverse perspectives.

Global Partnerships and Capacity Building

In an interconnected world, global partnerships and capacity-building initiatives are essential for addressing the global burden of kidney diseases, particularly in low-resource settings where access to kidney care is limited. Collaborative efforts between international organizations, governments, non-governmental organizations (NGOs), and academic institutions aim to improve access to essential medicines, diagnostic technologies, and renal replacement therapies, while also building local capacity for kidney care delivery and research.

Moreover, collaborative research networks and training programs facilitate knowledge exchange, skill development, and mentorship opportunities for nephrology professionals in resource-limited settings, empowering them to address local challenges and improve kidney health outcomes in their communities. By leveraging global partnerships and capacity-building initiatives, the nephrology nexus fosters equity, solidarity, and collective action in the fight against kidney diseases worldwide.

Conclusion

In conclusion, the nephrology nexus represents a collaborative ecosystem where stakeholders from diverse backgrounds come together to tackle the multifaceted challenges of kidney health. Through interdisciplinary collaboration, research consortia, patient engagement, global partnerships, and capacity-building initiatives, the nephrology nexus harnesses collective expertise, resources, and insights to drive innovation, improve outcomes, and advance kidney health for individuals worldwide. As we navigate the complexities of kidney diseases, let us continue to foster collaborative partnerships, amplify patient voices, and work together towards a future where every individual has access to equitable, high-quality kidney care.

0 notes

foresightintl · 14 days

Text

A Guide to Smart Purchase of Refurbished Ophthalmic Equipment

Refurbished ophthalmic equipment presents an enticing opportunity for healthcare facilities, eye clinics, and practitioners to acquire high-quality devices at a fraction of the cost of new ones. However, making informed decisions in this arena requires careful consideration of various factors. This article aims to guide prospective buyers through the process of purchasing refurbished ophthalmic equipment, highlighting the best practices and identifying the ideal candidates for such acquisitions.

Understanding Refurbished Ophthalmic Equipment:

Refurbished Ophthalmic Equipment refers to devices that have been previously used but have undergone thorough inspection, repair, and testing to ensure they meet manufacturer specifications and function like new. These devices can include slit lamps, fundus cameras, phoropters, and more.

Best Practices for Purchasing Refurbished Equipment:

Research Reliable Suppliers: Identify reputable suppliers or dealers with a proven track record in refurbishing ophthalmic equipment. Look for certifications and customer reviews to gauge reliability and quality assurance.

Inspect and Test: Prioritize suppliers who offer transparency regarding the refurbishment process and provide detailed inspection reports. Request demonstrations or trials to assess the equipment's performance firsthand.

Warranty and Support: Choose suppliers that offer warranties and after-sales support. A comprehensive warranty offers protection against probable malfunctions or faults as well as peace of mind.

Evaluate Total Cost of Ownership: Consider not only the upfront cost of the equipment but also factors such as ongoing maintenance, calibration, and future upgrades. Calculating the total cost of ownership helps in determining the long-term value of the investment.

Compliance and Certification: Ensure that refurbished equipment adheres to industry standards and regulations, such as FDA approvals and ISO certifications. Compliance with these standards indicates the equipment's safety and reliability.

Who Should Consider Purchasing Refurbished Ophthalmic Equipment?

Refurbished Ophthalmic Equipment can be helpful for many, some examples are below:

Small Clinics and Practices: For small clinics or practices with budget constraints, refurbished equipment offers a cost-effective solution without compromising on quality. It allows them to access advanced technology that may have been otherwise financially prohibitive.

Medical Schools and Training Facilities: Educational institutions can benefit from refurbished equipment to provide hands-on training to students without overspending on new devices. It facilitates practical learning experiences while minimizing financial strain.

Emerging Markets and Developing Countries: In regions where healthcare infrastructure is still developing, refurbished ophthalmic equipment can bridge the gap by providing essential diagnostic and treatment tools at affordable prices. It enables healthcare providers to deliver quality eye care services to underserved populations.

Refurbished Ophthalmic Equipment presents a viable option for healthcare facilities and practitioners seeking to upgrade their diagnostic and treatment capabilities while managing costs effectively. By following best practices such as researching reliable suppliers, inspecting equipment thoroughly, and considering total cost of ownership, buyers can make informed decisions and acquire high-quality devices with confidence. Whether for small clinics, educational institutions, or healthcare initiatives in developing regions, refurbished equipment offers a pathway to enhanced eye care accessibility and affordability.

0 notes

saanvi121 · 23 days

Text

Diploma in Pharmacovigilance: with IICRS to Advance Careers

Introduction:

In today's rapidly evolving healthcare landscape, the fields of clinical research and pharmacovigilance play pivotal roles in ensuring the safety and efficacy of medical treatments. As advancements in medical science continue to accelerate, the demand for skilled professionals in these areas is on the rise. For individuals seeking to embark on a rewarding career path in healthcare, obtaining specialized education and training is essential. In this blog, we delve into the significance of diplomas in Clinical Research & Pharmacovigilance and Diploma in Pharmacovigilance, and how International Institute of Clinical Research and Studies (IICRS) is leading the way in providing comprehensive education in these domains.

The Importance of Clinical Research and Pharmacovigilance:

Clinical research involves the investigation of new medications, devices, and treatment protocols to assess their safety, efficacy, and potential side effects. It plays a crucial role in bringing innovative healthcare solutions to patients while ensuring that rigorous scientific standards are upheld. Pharmacovigilance, on the other hand, focuses on the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems.

In an era where patient safety is paramount, the need for skilled professionals who can conduct clinical trials ethically and monitor the safety of pharmaceutical products throughout their lifecycle is more significant than ever. A diploma in Clinical Research & Pharmacovigilance equips individuals with the knowledge and expertise needed to excel in these dynamic and challenging fields.

Exploring Diploma Programs at IICRS:

At the International Institute of Clinical Research and Studies (IICRS), we are committed to providing high-quality education and training in clinical research and pharmacovigilance. Our diploma programs are designed to equip students with the practical skills and theoretical knowledge necessary to thrive in the pharmaceutical and healthcare industries.

Diploma in Clinical Research & Pharmacovigilance:

This comprehensive program covers a wide range of topics, including clinical trial design, regulatory affairs, pharmacology, adverse event reporting, and drug safety monitoring. Students gain hands-on experience through practical training modules, case studies, and industry internships, preparing them for roles such as clinical research associate, pharmacovigilance officer, drug safety specialist, and regulatory affairs associate.

Diploma in Pharmacovigilance:

Focused specifically on pharmacovigilance practices, this diploma program provides in-depth insights into adverse event reporting systems, risk management strategies, signal detection, and post-marketing surveillance. Students learn how to assess the safety profile of pharmaceutical products, identify potential risks, and implement measures to safeguard public health. Graduates of this program are well-positioned to pursue career opportunities in pharmacovigilance departments of pharmaceutical companies, regulatory agencies, and contract research organizations.

Why Choose IICRS?

International Institute of Clinical Research and Studies (IICRS) stands out as a premier institution for clinical research and pharmacovigilance education for several reasons:

Industry-Driven Curriculum: Our diploma programs are developed in collaboration with industry experts, ensuring that students receive training that is aligned with current industry standards and best practices.

Experienced Faculty: Our faculty members are seasoned professionals with extensive experience in clinical research, pharmacovigilance, regulatory affairs, and related fields. They bring real-world insights and practical knowledge to the classroom, enriching the learning experience for students.

Practical Training Opportunities: We believe in hands-on learning, which is why our diploma programs include practical training modules, industry projects, and internships with leading pharmaceutical companies and research organizations.

Career Support Services: From resume building workshops to mock interviews and networking events, we provide comprehensive career support services to help our graduates secure employment opportunities and advance their careers in clinical research and pharmacovigilance.

Conclusion:

A diploma in Clinical Research & Pharmacovigilance or Diploma in Pharmacovigilance from International Institute of Clinical Research and Studies (IICRS) opens doors to exciting career opportunities in the fast-paced and rewarding field of healthcare. With a strong emphasis on practical skills, industry relevance, and professional development, our programs empower students to make meaningful contributions to the advancement of medical science and the improvement of patient care. If you're passionate about making a difference in healthcare and shaping the future of medicine, consider enrolling in one of our diploma programs today and embark on a fulfilling career journey with IICRS.

#clinical research #Pharmacovigilance #Diploma in Pharmacovigilance

1 note · View note

resoveitech · 28 days

Text

Exploring Opportunities: The Essentials of a Clinical Research Course

Clinical research stands as a pivotal field bridging scientific discovery with practical application in healthcare. As the demand for advancements in medical treatments continues to rise, the importance of well-trained clinical researchers becomes increasingly evident. For those considering a career in this dynamic and impactful realm, undertaking a Clinical Research Course is a crucial step towards realizing their professional aspirations.

This article delves into the essentials of such a course, shedding light on its significance, content, and the myriad of opportunities it unlocks for aspiring professionals.

Understanding Clinical Research:

At its core, clinical research involves the investigation of new treatments, medications, and medical devices to enhance patient care and outcomes. It encompasses a spectrum of activities, including designing studies, collecting and analyzing data, and adhering to ethical and regulatory standards. A Clinical Research Course provides individuals with a comprehensive understanding of these fundamental aspects, laying a solid foundation for their future endeavors.

Content Highlights:

A well-designed Clinical Research Course covers a broad range of topics essential for success in the field. This may include:

1. Research Methodologies: Understanding various research designs, data collection methods, and statistical analysis techniques.

2. Regulatory Guidelines: Familiarizing with ethical principles, Good Clinical Practice (GCP) guidelines, and regulatory requirements governing clinical trials.

3. Protocol Development: Learning to draft and evaluate research protocols to ensure scientific rigor and participant safety.

4. Data Management: Acquiring skills in data collection, management, and analysis to derive meaningful insights from research findings.

5. Clinical Trial Operations: Gaining insights into the operational aspects of clinical trials, including recruitment strategies, site management, and monitoring procedures.

Unlocking Opportunities:

Completing a Clinical Research Course opens doors to a plethora of career opportunities in both academia and industry. Graduates may find employment as clinical research coordinators, data managers, regulatory affairs specialists, or medical writers. Moreover, the knowledge and skills acquired through such training are highly transferable, enabling individuals to explore diverse roles within the healthcare and pharmaceutical sectors.

Conclusion:

In conclusion, embarking on a Clinical Research Course is a strategic investment for individuals aspiring to make a meaningful impact in healthcare. By equipping them with essential knowledge, practical skills, and industry insights, these courses pave the way for a rewarding and fulfilling career journey. As the healthcare landscape continues to evolve, the need for competent clinical researchers remains steadfast, making this field ripe with opportunities for those willing to explore and seize them.

#ClinicalResearch #ClinicalResearchCourse #ClinicalResearchTraining #ClinicalResearchCenter #ClinicalResearchManagement #PhasesofClinicalResearch #ClinicalDataManagementCourse

0 notes

armorcorrectionalhealthservic · 1 month

Text

Advancing Healthcare Through Artificial Intelligence: Innovations, Opportunities, and Challenges

Artificial intelligence (AI) has emerged as a catalyst for transformation in the healthcare industry, offering innovative solutions to longstanding challenges and opening new avenues for improving patient care. From enhancing diagnostics and treatment planning to optimizing administrative workflows and drug discovery, AI-powered technologies hold immense promise in revolutionizing healthcare delivery. However, alongside these opportunities come significant challenges and ethical considerations that must be carefully navigated. In this article, we explore the evolving landscape of AI in healthcare, examining its innovation potential, the opportunities it presents, and the obstacles it must overcome to realize its full impact.

Transforming Diagnostics and Disease Management

One of the most compelling applications of AI in healthcare is its ability to augment diagnostic capabilities and improve disease management. Machine learning algorithms trained on vast datasets of medical images, such as X-rays, MRI scans, and histopathology slides, can assist healthcare professionals in detecting abnormalities and identifying patterns indicative of various diseases. For example, AI-powered image analysis tools can enhance the accuracy and efficiency of cancer diagnosis by identifying subtle changes in tissue morphology or detecting early signs of malignancy. Moreover, AI algorithms can analyze patient data to predict disease progression, stratify risk, and guide treatment decisions, enabling personalized care pathways tailored to individual patient needs.

Streamlining Administrative Processes

AI technologies are also transforming administrative workflows in healthcare, streamlining processes and reducing administrative burdens on healthcare providers. Natural language processing (NLP) algorithms can automate documentation tasks by transcribing clinical notes, extracting relevant information, and populating electronic health records (EHRs) with structured data. Additionally, AI-powered chatbots and virtual assistants can handle routine patient inquiries, schedule appointments, and provide real-time assistance, improving operational efficiency and patient experience. By automating repetitive tasks and reducing paperwork, AI enables healthcare professionals to focus more time and attention on delivering quality patient care.

Facilitating Drug Discovery and Development

The integration of AI into the drug discovery and development process has the potential to accelerate the pace of innovation in pharmaceutical research. AI algorithms can analyze large datasets of molecular structures, pharmacological properties, and clinical trial data to identify promising drug candidates, predict their efficacy, and optimize treatment regimens. For example, AI-powered platforms can expedite the identification of novel drug targets by analyzing genomic data and molecular pathways associated with disease progression. Moreover, AI-driven simulations and modeling techniques can predict the safety and efficacy of candidate drugs, reducing the time and cost associated with traditional drug development pipelines. By enabling more efficient and data-driven approaches to drug discovery, AI has the potential to bring new therapies to market faster and address unmet medical needs more effectively.

Empowering Patient-Centric Care

AI technologies empower patients to be more active in managing their health and well-being. Mobile health (mHealth) applications with AI-driven algorithms enable patients to monitor vital signs, track symptoms, and receive personalized health recommendations in real time. For example, wearable devices can continuously monitor physiological parameters, such as heart rate, blood pressure, and glucose levels, and alert patients and healthcare providers to potential health issues or deviations from normal ranges. Moreover, AI-powered virtual assistants can provide patients access to relevant health information, medication reminders, and lifestyle recommendations, empowering them to make informed decisions about their health and treatment options.

Addressing Challenges and Ethical Considerations

Despite its transformative potential, the widespread adoption of AI in healthcare is not without challenges and ethical considerations. One of the primary concerns is the need to ensure the reliability and interpretability of AI algorithms, particularly in critical decision-making processes such as diagnostics and treatment planning. Biases inherent in training data or algorithmic design can lead to erroneous predictions or exacerbate disparities in healthcare delivery, raising concerns about patient safety and fairness.

Moreover, the integration of AI into clinical workflows necessitates addressing issues related to data privacy, security, and regulatory compliance. Patient health data is susceptible, and strict measures must be in place to safeguard against unauthorized access, breaches, or misuse. Additionally, complying with existing regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States, requires careful consideration of data handling practices and transparency in AI-driven processes.

Furthermore, the ethical implications of AI in healthcare extend to questions of accountability, liability, and the potential loss of human touch in patient care. While AI can augment healthcare professionals' capabilities and improve decision-making, it cannot replace the empathy and intuition that characterize human interactions. Striking the right balance between leveraging AI's capabilities and preserving the human element in healthcare ensures patients receive compassionate and culturally sensitive care.

Artificial intelligence holds tremendous promise in transforming healthcare delivery, offering innovative solutions to improve diagnostics, streamline administrative processes, facilitate drug discovery, and empower patient-centric care. However, realizing this potential requires addressing significant challenges and ethical considerations, including algorithmic biases, data privacy concerns, and the preservation of human-centric care. By navigating these challenges thoughtfully and collaboratively, stakeholders can harness the full potential of AI to create a more efficient, equitable, and patient-centered healthcare system for the future.

0 notes

jcmarchi · 2 months

Text

A portable ultrasound tool uses AI to detect arm fractures more quickly - Technology Org

New Post has been published on https://thedigitalinsider.com/a-portable-ultrasound-tool-uses-ai-to-detect-arm-fractures-more-quickly-technology-org/

A portable ultrasound tool uses AI to detect arm fractures more quickly - Technology Org

A University of Alberta researcher is awarded $748,500 from Alberta Innovates to test a new portable ultrasound system that could shorten wait times and save money in hospital emergency departments.

A U of A researcher will use nearly $750,000 in new funding from Alberta Innovates to test a portable ultrasound system that uses AI to speed up triage for patients with suspected injuries to their wrists, elbows and shoulders.

The Ultrasound Arm Injury Detection tool uses artificial intelligence to allow triage nurses or primary care physicians to accurately scan for wrist or elbow fractures or tears in the rotator cuff.

According to Abhilash Hareendranathan, an assistant professor in the Department of Radiology and Diagnostic Imaging who developed the system, suspected injury to the upper limbs is responsible for one out of every five visits to emergency departments in Canada.

“What happens right now is people have to wait and — depending on which emergency department you go to and how busy they are that day — it could take from two to six hours to have an X-ray and then see the doctor,” Hareendranathan says. “With our tool, if you are able to rule out a fracture, that cuts down on the wait time and saves money on the diagnosis.”

The new tool uses AI to augment a portable ultrasound device, allowing the operator to determine whether an accurate scan has been captured and then reporting on whether a fracture has been detected.

The tool can be used by a “lightly trained” nurse or physician rather than requiring a sonographer or radiologist, who must train intensively to learn how to operate traditional diagnostic imaging equipment.

“The novice user often gets a good scan but they don’t know at what point to freeze the image, whereas in our system we automate that process,” explains Hareendranathan. “If it’s not a fracture, you will probably be given a painkiller and you’re good to go home.”

If a fracture is detected, the patient gets a followup X-ray or MRI scan to confirm the diagnosis and treatment plan, which can range from a simple splint to surgery for more severe injuries.

Hareendranathan has worked for a decade with a team of researchers who are striving to make portable ultrasound technology accessible outside of big-city hospitals. Radiologist Jacob Jaremko is now doing clinical trials on an AI-powered portable ultrasound system to detect hip dysplasia in newborns, and Kumaradevan Punithakumar, with the Servier Virtual Cardiac Centre at the Mazankowski Alberta Heart Institute, uses a combination of robotics and AI to produce 3D images of the heart using ultrasound.

“Ultrasound is fast, safe and highly sensitive to fractures, making it ideally suited for wrist examination in emergency departments,” Hareendranathan reported in a recently published research paper.

Hareendranathan has up to three years to clinically validate his system with patients at the pediatric emergency department of the Stollery Children’s Hospital and an MIC medical imaging clinic in Edmonton.

He’s confident the system will prove easy to use and “likable” to the staff there.

“These three conditions are not lethal by any stretch of the imagination, but their prevalence in emergency departments impedes treatment for more significant cases,” Hareendranathan says. “It’s a question of equity and also personalized treatment of the patient.”

“Funding medical innovations is critically important to advancing technologies from the lab into clinics around Alberta,” says Nate Glubish, Alberta minister of Technology and Innovation, who was at the U of A for today’s announcement of Alberta Innovates funding totalling $12.4 million for new health-care research. “That’s not only good for health innovation but for all Albertans.”

“Creating innovation in the health system requires support at all levels, from the earliest stages right through to those that are commercially viable,” says Laura Kilcrease, CEO of Alberta Innovates. “When innovators like those in the AICE – Concepts and LevMax-Health programs succeed, we achieve better patient outcomes and a stronger economy.”

Six other U of A projects will also receive funding from Alberta Innovates.

“The University of Alberta is a global leader in health research, and we’ve identified it as one of our top priorities,” says Aminah Robinson Fayek, U of A vice-president of research and innovation. “We’re grateful that Alberta Innovates supports our researchers’ efforts to get their life-changing innovations from the lab to the bedside, to help improve outcomes for patients in Alberta and beyond.”

Source: University of Alberta

You can offer your link to a page which is relevant to the topic of this post.

0 notes

certificationgdp · 2 months

Text

How can I ensure GLP certification?

GLP Certification in Lebanon

A GLP Certification in Lebanon would serve as a global gold standard for research excellence. In Lebanon, achieving GLP certification can unlock doors to international collaborations, enhance your research credibility, and build trust with regulatory bodies. But how do you ensure your existing quality management system (QMS) aligns with GLP requirements? Let’s explore a practical guide to bridge the gap and optimize your path to GLP certification in Lebanon.

What You Need to Know About GLP Certification in Lebanon

In the realm of scientific research, particularly within the pharmaceutical and environmental sectors, ensuring the quality and integrity of data holds paramount importance. This is where GLP Certification in Lebanon comes into play. By adhering to the rigorous standards the Organization for Economic Co-operation and Development (OECD) sets, GLP certification guarantees that non-clinical laboratory studies conducted in Lebanon meet internationally recognized criteria. However, navigating the path to GLP certification can seem daunting. This blog post aims to demystify the process, guiding you on ensuring GLP certification with the assistance of GLP Auditors and Consultants in Lebanon.

How GLP Certification Works in Lebanon

While Lebanon lacks a single entity formally awarding GLP certificates, the Ministry of Public Health (MoPH) oversees compliance with the OECD Principles of GLP through designated bodies. These principles encompass a comprehensive set of guidelines governing every facet of non-clinical laboratory studies, surrounding study design, data management, and personnel qualifications.

Benefits of GLP Certification in Lebanon

Obtaining GLP certification in Lebanon unlocks a multitude of advantages, including:

Enhanced Credibility and Trust: This certification is a third-party endorsement, showcasing your unwavering commitment to scientific integrity and transparency, fostering trust with regulatory bodies, collaborators, and the scientific community.

Global Market Access: Adherence to GLP principles enables international recognition of your research data, facilitating participation in global clinical trials and opening doors to lucrative collaborations with international partners.

Streamlined Regulatory Processes: By demonstrating compliance with GLP standards, you can expedite the regulatory approval process for new drugs, medical devices, and other products, saving time and resources.

Ensuring GLP Certification in Lebanon

To secure GLP certification in Lebanon, a multi-pronged approach is essential:

Embrace the Commitment: Recognize the ongoing commitment required to maintain GLP compliance. This includes investing in resources, personnel training, and establishing a culture of quality within your organization.

Conduct a Gap Analysis: Perform a thorough gap analysis to identify areas where your current practices may not align with the GLP principles. This involves critically evaluating your existing quality management system (QMS), standard operating procedures (SOPs), and training programs.

Develop a Robust QMS: Establish a comprehensive QMS outlining and documenting every aspect of your research operations by GLP principles. This includes SOPs for study design, data management, equipment maintenance, and personnel training.

Invest in Training: Ensure all personnel involved in non-clinical studies undergo comprehensive training on GLP principles and their practical application within your research context.

Seek Expert Guidance: Partner with qualified GLP consultants in Lebanon. These experts possess extensive knowledge of the GLP principles and the Lebanese regulatory landscape. They can guide you through the entire process, offering valuable services such as:

Gap analysis and QMS development

Developing and implementing training programs

Conducting mock audits and identifying areas for improvement

Liaising with the MoPH and designated bodies

Providing ongoing support and guidance

Prepare for Inspection: After implementing the necessary changes and improvements, prepare for the MoPH inspection conducted by designated bodies. This involves ensuring all documentation is accurate and readily available for review by the inspectors.

The Role of GLP Auditors in Lebanon:

While Lebanon doesn’t have a specific certification program for GLP auditors, individuals interested in pursuing this career path can obtain qualifications abroad and offer their services to laboratories seeking GLP compliance. These qualified auditors play a crucial role by providing independent, objective assessments of a laboratory’s adherence to the GLP principles.

Conclusion:

Obtaining GLP Certification in Lebanon requires dedication, meticulous preparation, and the support of qualified professionals. By diligently following the outlined steps, partnering with GLP consultants in Lebanon, and embracing the continuous improvement mindset inherent in GLP principles, you can ensure successful certification and elevate the quality and integrity of your research endeavors, ultimately contributing to advancements in various scientific fields.

Conclusion:

GLP certification in Lebanon is not just about compliance; it’s about embracing a culture of excellence and quality in scientific research. By committing to this journey, you contribute to a brighter future for science, public health, and your organization’s GLP Certification in Canada.

What makes Factocert the best choice for GLP Certification in Lebanon

We provide the best GLP Certification in Lebanon, Who are knowledgeable and provide the best solutions. And how to get ISO certification in Lebanon. Kindly reach us at [email protected]. GDP consultants in Lebanon work according to GLP standards and help organizations implement GLP Certification with proper documentation.

For more information, visit GLP Certification in Lebanon.